Zelboraf Approved for Use in Erdheim-Chester Disease
Kinase inhibitor (vemurafenib) for use in patients with BRAF V600 mutation
ASCO Issues Statement Regarding Alcohol and Cancer
Alcohol-related cancers account for 5.5 percent of all cancers treated annually worldwide
Delay in Tranexamic Acid Administration Reduces Benefit
Survival benefit decreases by 10 percent for every 15-minute delay in treatment for severe bleeding
Glycosylation Differences in Egg-Adapted Vaccines May Cut Impact
H3N2 egg-adapted vaccines, circulating strains were different in 2016-2017 influenza season
Sodium Oxybate Promising for Parkinson’s, Daytime Sleepiness
Improvements in subjective sleep quality, objectively measured slow-wave sleep duration
Evidence Scant for Treatment of Cough With the Common Cold
Update recommends against nonsteroidal anti-inflammatory agents for adults, codeine for children
Increases in U.S. Health Spending Tied to Health Service Price
Higher spending also linked to population growth and aging, negatively linked to disease incidence
In ER, Combination of Ibuprofen, Acetaminophen Relieves Pain
No difference in pain reduction for ibuprofen and acetaminophen vs. 3 opioid/acetaminophen combos
Lymphoma Risk Up With Thiopurine, Anti-TNF Tx in IBD
Risk higher for those exposed to combination therapy versus thiopurine or anti-TNF monotherapy
Drop in Incidence of End-Stage Renal Disease Due to Diabetes
2000 to 2014 saw decrease in incidence of ESRD with diabetes listed as the primary cause
